Janney Montgomery Scott
AXSM icon

Janney Montgomery Scott’s Axsome Therapeutics AXSM Stock Holding History

Janney Montgomery Scott’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.2M Buy
13,087
+1,057
+9% +$229K 0.01% 1221
2026
Q1 		$2.03M Buy
12,030
+550
+5% +$95K 0.01% 1278
2025
Q4 		$2.1M Sell
11,480
-1,525
-12% -$213K ﹤0.01% 1311
2025
Q3 		$1.58M Sell
13,005
-18
-0.1% -$2.03K ﹤0.01% 1434
2025
Q2 		$1.36M Sell
13,023
-1,900
-13% -$201K ﹤0.01% 1406
2025
Q1 		$1.74M Buy
14,923
+1,178
+9% +$134K ﹤0.01% 1223
2024
Q4 		$1.16M Buy
13,745
+6,546
+91% +$602K ﹤0.01% 1454
2024
Q3 		$647K Buy
7,199
+1,569
+28% +$137K ﹤0.01% 1787
2024
Q2 		$453K Sell
5,630
-150
-3% -$11.1K ﹤0.01% 1962
2024
Q1 		$461K Buy
5,780
+500
+9% +$42K ﹤0.01% 2063
2023
Q4 		$420K Sell
5,280
-280
-5% -$18.7K ﹤0.01% 2024
2023
Q3 		$389K Buy
5,560
+1,073
+24% +$80.2K ﹤0.01% 1962
2023
Q2 		$322K Buy
+4,487
New +$331K ﹤0.01% 2181
2023
Q1 		– Sell
-2,805
Closed -$216K – 2527
2022
Q4 		$216K Buy
+2,805
New +$168K ﹤0.01% 2327
2022
Q2 		– Sell
-5,722
Closed -$237K – 2315
2022
Q1 		$237K Sell
5,722
-327
-5% -$10.1K ﹤0.01% 1999
2021
Q4 		$229K Buy
+6,049
New +$223K ﹤0.01% 2161
2021
Q3 		– Sell
-10,540
Closed -$711K – 2287
2021
Q2 		$711K Buy
10,540
+500
+5% +$30K ﹤0.01% 1443
2021
Q1 		$568K Buy
10,040
+85
+0.9% +$5.98K ﹤0.01% 1484
2020
Q4 		$811K Buy
9,955
+312
+3% +$23.3K ﹤0.01% 1284
2020
Q3 		$687K Sell
9,643
-1,129
-10% -$88K ﹤0.01% 1270
2020
Q2 		$886K Buy
10,772
+2,416
+29% +$186K 0.01% 1084
2020
Q1 		$492K Sell
8,356
-14,004
-63% -$1.14M ﹤0.01% 1227
2019
Q4 		$2.31M Sell
22,360
-6,115
-21% -$247K 0.02% 741
2019
Q3 		$576K Buy
28,475
+950
+3% +$24.4K ﹤0.01% 1308
2019
Q2 		$709K Buy
27,525
+9,950
+57% +$199K 0.01% 1223
2019
Q1 		$250K Buy
+17,575
New +$163K ﹤0.01% 1748

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Janney Montgomery Scott's AXSM Position: Q2 2026 in Review

Janney Montgomery Scott increased its Axsome Therapeutics (AXSM) stake by 8.8% in Q2 2026, buying an estimated $229K and bringing the position to 13,087 shares worth $3.2M. The position accounts for 0.01% of the portfolio, ranked #1221.

Janney Montgomery Scott first reported a position in AXSM in Q1 2019 and has held it in 26 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Janney Montgomery Scott held 13,087 shares of Axsome Therapeutics worth $3.2M as of Q2 2026.
  • Janney Montgomery Scott bought 1,057 Axsome Therapeutics shares in Q2 2026, an estimated $229K.
  • Axsome Therapeutics made up 0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #1221 holding.
  • Janney Montgomery Scott first reported a position in Axsome Therapeutics in Q1 2019 and has held it in 26 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.